Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression
- 1 May 2002
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 51 (9) , 753-761
- https://doi.org/10.1016/s0006-3223(01)01317-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetineClinical Therapeutics, 2001
- A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertralineClinical Therapeutics, 1999
- Drugs That Cause Weight GainObesity Research, 1995
- Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depressionJournal of Affective Disorders, 1993
- Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depressionInternational Clinical Psychopharmacology, 1993
- Recognition and management of depression in general practice: consensus statement.BMJ, 1992
- The place of obsessive compulsive disorder in the diagnostic hierarchyInternational Clinical Psychopharmacology, 1992
- Three-Year Outcomes for Maintenance Therapies in Recurrent DepressionArchives of General Psychiatry, 1990
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959